UNMATCHED SUPPLY CHAIN SOLUTIONS FOR THE LIFE SCIENCES INDUSTRY

643
Active Clinical Trials
9
Commercial Products
600,000+
Shipments
150+
Countries
Cryoport_Q3_2022_Box 
2022’s Data ManagementTransitionsWebinar

2022’s Data Management Transitions Webinar

Are your advanced therapy supply chains ready for this year’s 4G/LTE data management transition?

  • How will capacity and connectivity challenges impact carrier services and packaging technology providers?
  • How can you guarantee the certainty of global coverage and data fidelity for your cell and gene therapy shipments?
WATCH NOW
Download our ISO 21973 White Paper

Download our ISO 21973 White Paper

A leap forward in standardizing the regenerative medicine supply chain

  • Ensuring full compliance at every step in the transportation process
  • Standardization at scale
  • Mitigating risk in a zero failure environment
LEARN MORE

Upcoming Events View All

NOV25

48th BSRM Scientific Meeting

Date: November 25-26, 2022
Location: Bruges, Belgium

DEC5

Cell & Gene Therapy Manufacturing & Commercialization Europe 2022

Date: December 5-8, 2022
Location: Amsterdam, The Netherlands

The Latest From Our Blog View All

Cryoport's Chain of Compliance®: Collects, Interprets, and Leverages Comprehensive Data to Enable a Significantly Smarter Supply Chain

Companies vying to be the first to market with breakthrough treatments have a great deal riding on the success of their efforts. Incorporating innovative processes, ethical considerations, assuring the safety and efficacy of the product, and managing the commodity's environmental control are formidable challenges that often lack standardized quality control procedures. Precision medicine requires end-to-end traceability: everything from chain of custody, to chain of condition, to chain of identity. The fragility of regenerative medicine therapies and the need to manage risk means a fourth link in the chain will soon be a regulatory requirement.  

Cryoshuttle® Local Delivery and Pickup: Now Serving More Areas

Many biopharmaceutical companies, academic institutions, and manufacturing sites often need to move their valuable life-saving therapies and research materials locally for a variety of reasons, such as lab relocation or drug product administration on the patient. Local shipments require just as much care and attention as any long-distance transport, and Cryoport Systems has created a specialized solution to mitigate risk even further for those local deliveries. Cryoport owns and operates an in-house fleet of shuttles, Cryoshuttle®, which provides convenient and personalized local pickup and delivery service in select geographical regions that are in proximity to Cryoport Systems’ Global Logistics and Supply Chain Centers. We are proudly serving the Southern California area including Los Angeles, Orange County and San Diego, the Houston Metropolitan Area in Texas, New York City Metro and New Jersey, as well as internationally around Amsterdam, The Netherlands. 

Cryoport® is a trademark of Cryoport, Inc. and used with permission by Cryoport Systems, LLC

Cryoport Systems has officially launched our BioServices solutions through our two new Global Supply Chain Centers. Learn More